Navigation Links
Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
Date:10/26/2012

AUSTIN, Texas, Oct. 26, 2012 /PRNewswire/ -- Altogen Labs announced the filing of a patent for bioremediation microorganism isolation and selection methods (USPTO application 13/490,508). This environmental technology is based on isolation of naturally present microorganisms in heavily contaminated soil, which allows accelerating natural bioremediation processes. We don't have to wait hundreds of years for nature to degrade an oil spill or clean up land contaminated with toxic chemicals and carcinogens. Instead, by reintroducing natural bacteria to oil spill sites, Altogen Labs accomplish oil degradation process in just a few months. This bioaugmentation platform technology to remediate crude oil and chemical spills can be applied worldwide.

Both laboratory and field tests showed that Altogen Labs site-specific bacterial strains are highly effective for remediation of crude oil- and petroleum-saturated earth. The bacteria is grown in the lab to speed up the natural process and then re-introduced to the contaminated site. Multiple lab studies show that after consuming the oil and having no remaining food source, the bacteria die. No adverse effects of using the live bacteria have been observed, and the effectiveness and safety of the method are remarkable. Scientists at Altogen Labs used functional genomics to perform whole genome sequencing study to characterize these newly identified natural microorganisms and identify specific biosurfactant and quorum-sensing genes that allow the microorganisms to work together for efficient and effective crude oil spill bioremediation.

Altogen Labs also offers soil remediation services and development programs focused on other chemical contaminations besides crude oil, including remediation of soil with recalcitrant organic chemical spills including polycyclic aromatic hydrocarbons, petroleum, pesticides, herbicides, perchlorate, carbon tetrachloride, chloroform, acetone, benzene, toluene, xylenes, perchloroethylene, chlorofluorocarbon, aliphatic chlorinated hydrocarbons, and other industrial and chemical manufacturing wastes and spills.

Altogen Labs announced that site-specific bioremediation products will be manufactured and sold through its exclusive distributor - Soil Bioremediation Inc (www.soil-bio-remediation.com) located in Austin, Texas.

About Altogen Labs

Altogen Labs (www.altogenlabs.com) is GLP compliant laboratory that provides biotechnology research services and biology CRO services to pharmaceutical, biotechnology, and academic institutions worldwide. Bioremediation is one of the company's focus areas. This bioaugmentation-based soil remediation technology provides conversion of toxic, environment-contaminating compounds into innocuous substances by using natural oil-degrading bacteria.

Contact
Altogen Labs
4020 South Industrial Dr, Suite 130
Austin TX 78744 USA
(512) 433-6177
Web: www.altogenlabs.com
E-mail: info@altogenlabs.com


'/>"/>
SOURCE Altogen Labs
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 ... Company, has expanded its customisable SureSeq™ NGS panel range with ... - allowing fast and cost-effective study of variants in familial ... copy number variation (CNV) detection on a single small panel ... and hotspot content. This includes all exons for LDLR ...
(Date:12/8/2016)... Iowa (PRWEB) , ... December 08, 2016 , ... This ... asynchronous approvals for biotech crops. The authors focus on the economic effects in countries ... global approval of new biotech crops and the resultant risk of low level presence ...
(Date:12/8/2016)... Dec. 8, 2016 Eutilex Co. Ltd. today ... (US $18.9M) Series A financing. This financing round included ... Venture and SNU Bio Angel. This new funding brings ... KRW (US $27.7M) since its founding in 2015. ... the development and commercialization of its immuno-oncology programs, expand ...
(Date:12/7/2016)... ... 07, 2016 , ... Huffman Engineering, Inc. , a ... Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based company recognized ... Integrator Partner certification gives customers confidence that our engineers are fully trained and ...
Breaking Biology Technology:
(Date:11/21/2016)... Lithuania , Nov. 21, 2016   ... and object recognition technologies, today announced that the ... smart cards was submitted for the NIST ... successfully passed all the mandatory steps of the ... evaluation is a continuing test of fingerprint templates ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
Breaking Biology News(10 mins):